MedPath

VH tablet(Ayurvedic herbal formulation) for hyperlipidemia to decrease cholestrol levels.

Phase 3
Conditions
Health Condition 1: E785- Hyperlipidemia, unspecified
Registration Number
CTRI/2024/07/071755
Lead Sponsor
Dr Nikita Ganthale
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Known case of hyperlipidemic patients

Patient willing to participate in the study

Exclusion Criteria

Patients with comorbid conditions (uncontrolled hypertension, uncontrolled diabetes mellitus, renal and liver dysfunction)

Pregnant women and lactating mothers

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Decreased Lipid values.Timepoint: 30 days <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
reduced symptoms in patients,Decreased hip circumference,decreased waist circumference, decreased hip:waist circumference ratioTimepoint: 30 days <br/ ><br>
© Copyright 2025. All Rights Reserved by MedPath